Skip to content

Study · Randomized controlled trial · 2010

2 results

Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors.

Martínez F, Clua E, Santmartí P, Boada M, Rodriguez I, Coroleu B

Fertility and sterility28 Apr 2010Cited by 10 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In donor-egg recipients, cetrorelix and the long leuprorelin protocol did not differ significantly in implantation rates per transfer.

    In plain wordsIn donor-egg recipients, implantation rates per transfer did not differ significantly between cetrorelix and the long leuprorelin protocol.

    Peptide
    Cetrorelix
    Outcome
    No significant changeImplantation rate per transfer
    Study

    n: not reported in source

    Comparator
    Long depot leuprorelin protocol
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Single 3 mg doseAs given in this study (human).

    Measurements

    Implantation rate per transfer
    42.3%
    Cetrorelix
    Implantation rate per transfer
    30.5%
    Long protocol

    Source sentences

    Summary
    In a pilot study, implantation and pregnancy rates per transfer were favorable in recipients of donated eggs treated with a single dose of cetrorelix acetate 3 mg compared with recipients of donated eggs treated with the long protocol (42.3% vs. 30.5%, and 71.0% vs. 46.7%, respectively; NS).
    1 context sentence
    Title · context
    Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors.
  2. 02HumanRandomized controlled trialEfficacy outcome

    In donor-egg recipients, cetrorelix and the long leuprorelin protocol did not differ significantly in pregnancy rates per transfer.

    In plain wordsIn donor-egg recipients, pregnancy rates per transfer did not differ significantly between cetrorelix and the long leuprorelin protocol.

    Peptide
    Cetrorelix
    Outcome
    No significant changePregnancy rate per transfer
    Study

    n: not reported in source

    Comparator
    Long depot leuprorelin protocol
    Outcome group
    Sex hormones and fertility · Reproductive and sexual health
    Studied dose
    Single 3 mg doseAs given in this study (human).

    Measurements

    Pregnancy rate per transfer
    71%
    Cetrorelix
    Pregnancy rate per transfer
    46.7%
    Long protocol

    Source sentences

    Summary
    In a pilot study, implantation and pregnancy rates per transfer were favorable in recipients of donated eggs treated with a single dose of cetrorelix acetate 3 mg compared with recipients of donated eggs treated with the long protocol (42.3% vs. 30.5%, and 71.0% vs. 46.7%, respectively; NS).
    1 context sentence
    Title · context
    Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:35 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.